Table 3.
Sample | Conc. mg/kg p.o. |
Antibody titre Mean ± S.E. |
% Activity |
DTH Mean ± S.E. |
% Activity |
---|---|---|---|---|---|
Control | — | 6.5 ± 0.21 | — | 0.80 ± 0.16 | — |
| |||||
Cyclophosphamide | 200 | 4.5 ± 0.21 | −30.7 | — | — |
| |||||
Cyclosporine | 5 | — | — | 0.35 ± 0.10 | −56.25 |
| |||||
Levamisole | 2.5 | 7.16 ± 0.22 | +133 | 1.11 ± 0.22 | +168 |
| |||||
AJL1-H (mg/mL) | 100 | 7.33 ± 0.21 | +141 | 1.11 ± 0.22 | +168 |
50 | 5.83 ± 0.16 | +67 | 0.80 ± 0.16 | +100 | |
25 | 3.83 ± 0.16 | +33 | 0.91 ± 0.16 | +124 | |
| |||||
AJL1-C (mg/mL) | 100 | 5.83 ± 0.16 | +67 | 0.48 ± 0.21 | −29 |
50 | 4.66 ± 0.21 | +8 | 0.45 ± 0.22 | +23 | |
25 | 5.16 ± 0.16 | +33 | 0.60 ± 0.20 | +56 | |
| |||||
AJL1-E (mg/mL) | 100 | 5.66 ± 0.21 | +58 | 0.63 ± 0.21 | +63 |
50 | 5.16 ± 0.16 | +33 | 0.41 ± 0.16 | +14 | |
25 | 5.33 ± 0.21 | +42 | 0.50 ± 0.22 | +34 | |
| |||||
AJL1-A (mg/mL) | 100 | 6.33 ± 0.21 | +91 | 0.80 ± 0.16 | +100 |
50 | 6.16 ± 0.40 | +83 | 0.83 ± 0.16 | +106 | |
25 | 5.33 ± 0.21 | +42 | 0.53 ± 0.21 | +40 | |
| |||||
AJL1-M (mg/mL) | 100 | 5.16 ± 0.16 | +33 | 0.58 ± 0.16 | +52 |
50 | 4.16 ± 0.16 | −17 | 0.38 ± 0.22 | −7 | |
25 | 6.5 ± 0.22 | +100 | 0.93 ± 0.21 | +128 |
Values are expressed as mean ± standard deviation.